Drug intelligence / Profile preview

citalopram + tipepidine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Citalopram + tipepidine is a combination of two small molecule drugs. Citalopram is a selective serotonin reuptake inhibitor (SSRI) used primarily for the treatment of depression and major depressive disorder. It works by inhibiting the reuptake of serotonin in the brain, thereby increasing its availability and enhancing serotonergic neurotransmission[1][2][3]. Tipepidine is an antitussive agent (cough suppressant) that acts as a non-opioid central cough suppressant, believed to exert its effect through inhibition of G-protein-coupled inwardly rectifying potassium channels (GIRK), though it may also have some serotonergic activity. The combination would theoretically provide both antidepressant effects from citalopram and cough suppression from tipepidine; however, there are no widely recognized or approved fixed-dose combinations of these two agents.

02

Targets

SERT (Sodium-dependent serotonin transporter)KACh (G protein–activated inwardly rectifying potassium channel)

Beyond the preview

Go deeper on citalopram + tipepidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on citalopram + tipepidine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call